Companies: 10,795·Total market cap: $144.5T
Biophytis S.A.

Biophytis S.A.

BPTSYOTCHealthcare● Active
$0.25
+$0.00(+0.00%)
Market Cap$105224
P/E Ratio—
52W High$3.36
52W Low$0.001
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Biophytis S.A. (BPTSY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001768946 · BPTSY · OTC · as of Jun 9, 2026

Filing snapshot

216
Total Filings
6-K
Latest Form
2026-06-09
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001768946 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2024-04-08
Fiscal Year End
Apr 8, 2024
Accession No.
0001104659-24-044790
Primary Document
bpts-20231231x20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001768946 · Accession 0001104659-24-044790

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-06-09
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-09
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-28
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-30
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-26
View
DD
D
2026-03-23
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-11
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-27
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-28
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-01-21
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-11-14
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-10-31
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-10-17
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-10-14
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-09-15
View
Showing 1–15 of 216 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001768946  |  Exchange: OTC · Healthcare

Biophytis S.A. (OTC: BPTSY) has submitted 216 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001768946, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Biophytis S.A.'s most comprehensive regulatory disclosure. The most recent Biophytis S.A. 10-K was filed on 2024-04-08 for fiscal year ending 2024. Historical BPTSY 10-K annual reports are available from 2019 through 2024.

Investors researching Biophytis S.A. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
BITRF SEC Filings →RSPI SEC Filings →TSOI SEC Filings →VIRX SEC Filings →RASP SEC Filings →IPIX SEC Filings →YECO SEC Filings →PFND SEC Filings →
→ BPTSY Financials→ BPTSY Earnings→ BPTSY Insider Trades

Frequently Asked Questions

BPTSY SEC Filings · 8 questions

Biophytis S.A. (BPTSY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 216 filings and access original documents at no cost. Biophytis S.A.'s CIK is 0001768946.

BPTSY SEC filingsBiophytis S.A. SEC documentsfind BPTSY 10-K